上皮性卵巢癌患者非家庭出院预测模型的 External 验证
本研究在三个学术医疗体系的医学中心对2010年1月至2015年12月接受初次肿瘤细胞减灭术的上皮性卵巢癌患者进行外部验证,共纳入204例入院记录。非家庭出院率为12%(95% CI 8-18%),预测模型的一致性指数为0.86(95% CI 0.76-0.93),与原始研究(CI 0.88)相似。结论认为该模型可准确预测非家庭出院。
要点
- 非家庭出院率为12%(95% CI 8-18%),非家庭出院患者中位住院时间8天 vs 5天(P < 0.001)。
- 模型一致性指数为0.86(95% CI 0.76-0.93),与原始研究(CI 0.88)相似。
- 模型在所有概率范围(0至100%)内均提供准确预测。
核心结论
- 使用术前临床变量可准确预测非家庭出院。
- 使用该验证后的非家庭出院预测模型可能有助于术前患者咨询、早期出院规划并可能降低医疗费用。
研究设计与样本
- 外部验证研究,纳入2010年1月至2015年12月在学术医疗体系内三个三级医学中心接受初次开腹肿瘤细胞减灭术的上皮性卵巢癌女性。
- 排除接受新辅助化疗、非上皮性恶性肿瘤、非初次肿瘤细胞减灭术或缺乏模型组件记录的患者。
- 共204例入院记录符合纳入标准。
主要发现
- 非家庭出院(包括专业护理机构、急性康复机构、临终关怀或住院死亡)总体发生率为12%(95% CI 8-18%)。
- 平均年龄为60.8岁(标准差11.0)。
- 非家庭出院患者的中位住院时间显著更长(8天 vs 5天,P < 0.001)。
- 预测模型的一致性指数为0.86(95% CI 0.76-0.93),与原始研究(CI 0.88)相似。
- 模型在所有概率(0至100%)范围内均提供准确预测。
关键数值与推荐
- 预测模型使用年龄、术前CA-125、美国麻醉医师协会(ASA)评分和东部肿瘤协作组(ECOG)体能状态计算非家庭出院的预测概率。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To externally validate a model predicting non-home discharge in women undergoing primary cytoreductive surgery (CRS) for epithelial ovarian cancer (EOC). METHODS: Women undergoing primary CRS via laparotomy for EOC at three tertiary medical centers in an academic health system from January 2010 to December 2015 were included. Patients were excluded if they received neoadjuvant chemotherapy, had a non-epithelial malignancy, were not undergoing primary cytoreduction, or lacked documented model components. Non-home discharge included skilled nursing facility, acute rehabilitation facility, hospice, or inpatient death. The predicted probability of non-home discharge was calculated using age, pre-operative CA-125, American Society of Anesthesiologists (ASA) score and Eastern Cooperative Oncology Group (ECOG) performance status as described in the previously published predictive model. Model discrimination was calculated using a concordance index and calibration curves were plotted to characterize model performance across the cohort. RESULTS: A total of 204 admissions met inclusion criteria. The overall rate of non-home discharge was 12% (95% CI 8-18%). Mean age was 60.8 years (SD 11.0). Median length of stay (LOS) was significantly longer for patients with non-home discharge (8 vs. 5 days, P < 0.001). The predictive model had a concordance index of 0.86 (95% CI 0.76-0.93), which was similar to model performance in the original study (CI 0.88). The model provided accurate predictions across all probabilities (0 to 100%). CONCLUSIONS: Non-home discharge can be accurately predicted using preoperative clinical variables. Use of this validated non-home discharge predictive model may facilitate preoperative patient counseling, early discharge planning, and potentially decrease cost of care.
引用
- Connor EV, Newlin EM, Jelovsek JE, et al. Predicting non-home discharge in epithelial ovarian cancer patients: External validation of a predictive model. Gynecol Oncol. 2018. PMID: 30107886. doi:10.1016/j.ygyno.2018.08.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。